Skip to main content

Table 2 Prescribed ASCVD related treatment

From: Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon

Drug

Overall [95% CI]

Abdeh clinic [95% CI]

DAZ clinic [95% CI]

ACE-I or ARB

75.7 [71.7, 79.3]

80.3 [74.64, 85.1]

71.8 [66.0, 77.0]

Statin

98.2 [96.5, 99.1]

95.6 [93.1, 98.4]

99.6 [97.7, 100]

Antiplatelet

97.3 [95.3, 98.4]

95.3 [91.5, 97.5]

98.9 [96.6, 99.7]

Β-blocker (BB)

79.1 [75.2, 82.5]

73.8 [67.6, 79.2]

83.5 [78.5, 87.6]

Statin, antiplatelet, ACE-I/ARB

73.5 [69.4, 77.3]

76.4 [70.3, 81.6]

71.1 [65.2, 76.3]

Statin, antiplatelet, ACE-I/ARB/BB

83.2 [79.6, 86.3]

79.8 [74.0, 84.7]

86.1 [81.3, 89.8]